Clinical Trials Browser

Phase EARLY_PHASE1 × Leukemia, Myeloid × 90 days × Clear all

NCT05035706 2026-03-05

Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors

Phase EARLY_PHASE1 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute